Quantitative Profile of Serum Proteins
Advanced Protein Biomarker Testing in Traumatic Brain Injury Patients
BioCentra Diagnostics, CAP-CLIA -Accredited High Complexity Diagnostics Laboratory, has developed a unique and advanced gene and protein biomarker assay panel to determine the severity of neurological trauma in personal injury (PI) cases, particularly those resulting in traumatic brain injury (TBI) and long-term neurological dysfunction (ND). This innovative tool is anticipated to be highly valuable for lawyers pursuing increased reimbursements from insurance companies, for physicians looking for increased revenues while offering personalized treatments, and for patients seeking improved care and compensation for their injuries.
Traumatic brain injury (TBI) is a global neurological disorder of epidemic scale, with no FDA-approved therapies currently available to treat any form of TBI. However, promising data indicate that biofluid-based biomarker tests are emerging as a valuable tool for diagnosing TBIs across varying severities, including concussions, and for predicting patient outcomes. These advancements offer hope for more accurate diagnoses and improved management of TBI in the future.
Our company has developed a groundbreaking blood-based biomarker (BBM) panel specifically designed to detect, quantify, and interpret biomarkers associated with Traumatic Brain Injury (TBI). This novel BBM-TBI Test has undergone a rigorous validation process in our laboratory, adhering to CAP and CLIA standards, ensuring high sensitivity and specificity in its results. The objective, quantitative data provided by our test supports accurate TBI diagnoses, informs additional diagnostics, and aids in developing targeted treatments. Our BBM-TBI Test is now available for clinical use nationwide.
The importance of testing cannot be overstated. Many TBIs are missed in emergency rooms or overlooked in imaging due to their small size or early onset. Traditional diagnostics, including imaging and neuropsychological assessments, are often subjective, leading to missed diagnoses. Over 50% of TBIs currently go undetected, with acute cases being particularly challenging to diagnose. Our BBM-TBI Test offers an objective solution, ensuring that patients receive the proper diagnosis to explain their symptoms and support necessary treatments and additional diagnostics.
We are committed to enhancing both innovation and logistics to meet the needs of our clients. Our services include customized ordering options, mobile phlebotomy available nationwide, and results delivered in less than 48 hours. We also provide a secure online portal for physicians and law offices to access test results, streamlining the process and ensuring confidentiality.
In addition to our testing services, we provide exceptional customer support. Our team offers live customer service, on-demand clinical support, and expert witness testimony for personal injury cases, ensuring that our clients receive comprehensive and reliable assistance throughout their experience with our company.
